Trial intelligence / Profile preview

Combined NRT vs Single NRT for Smoking Cessation in Hong Kong

NCT03836560Completed

Sponsor
Hospital Authority
Start
Dec 2012
Primary completion
Feb 2018
Modality
Transdermal Patches, Small Molecules
01

Overview

Randomised, open-label trial of nicotine patch in Tobacco Use Disorder (TUD) (2 arms), sponsored by Hospital Authority. Primary endpoint: 7-day point-prevalence abstinence rate at 52 weeks. Started Dec 2012; status: completed.

02

Drugs

nicotine patch
03

Conditions

Tobacco Use Disorder (TUD)

Beyond the preview

Go deeper on NCT03836560.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT03836560.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call